查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873242

全球內視鏡黏膜切除術技術市場

Endoscopic Mucosal Resection Technology
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球內視鏡黏膜切除術技術市場預計到2030年將達到57億美元。

2024年全球內視鏡黏膜切除術市場規模估計為37億美元，預計到2030年將達57億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為7.6%。本報告分析的細分市場之一－提拉切開術，預計複合年成長率為6.6%，到分析期末將達到30億美元。囊袋切開術細分市場預計在分析期間內複合年成長率為8.8%。

美國市場規模估計為10億美元，而中國市場預計將以7.1%的複合年成長率成長。

據估計，到2024年，美國內視鏡黏膜切除術（EMR）技術市場規模將達10億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到8.779億美元，2024年至2030年的複合年成長率（CAGR）為7.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的複合年成長率將分別達到6.8%和6.2%。在歐洲，德國的複合年成長率預計將達到約6.4%。

全球內視鏡黏膜切除術技術市場—主要趨勢與促進因素概述

內視鏡黏膜切除術技術如何革新胃腸道癌症的治療？

內視鏡黏膜切除術(EMR) 技術正在革新胃腸道癌症的治療，它為切除胃腸道癌前病變和早期癌症提供了一種微創且高效的選擇。 EMR 在治療食道癌、胃癌和大腸直腸癌等疾病方面尤其重要，因為早期發現並切除異常組織可以防止病情發展至晚期。此技術使用內視鏡（配備攝影機和器械的軟管）切除胃腸道黏膜層，無需傳統手術即可去除異常組織。 EMR 不僅降低了開放性手術的風險和縮短了恢復時間，還能保護胃腸道的結構，維持病患的正常功能和生活品質。隨著人們對胃腸道癌症的認知不斷提高以及篩檢的普及，EMR 已成為一種早期、微創的癌症治療治療方法，有望顯著改善患者的預後。

哪些創新正在增強內視鏡黏膜切除術（EMR）技術的功能？

內視鏡黏膜切除術(EMR) 技術的創新正透過影像、切除和輔助性治療的進步不斷提升其功能。其中一項最重要的進展是將高清影像與先進的內視鏡技術相結合，例如窄頻成像 (NBI) 和染色內視鏡。這使得異常組織的辨識和界定更加精準，使胃腸病學家能夠發現以往容易被忽略的微小病變。這提高了切除術的有效性和安全性。另一項關鍵創新是混合 EMR 技術的開發，該技術將傳統切除術與黏膜下注射和使用專用切除器械等其他技術相結合。這使得更大、更複雜的病變能夠被完整且可控地切除，最大限度地降低了切除不完全和復發的風險，並提高了手術的長期成功率。此外，將內視鏡黏膜下切除術（EMR）與射頻消融術（RFA）和冷凍療法等輔助性治療結合，擴大了其適用病灶的範圍，並改善了疑難病例的治療效果。這些創新使EMR更加有效、安全且易於實施，鞏固了其作為胃腸道腫瘤早期治療重要手段的地位。

內視鏡黏膜切除術（EMR）如何影響患者的治療結果與治療選擇？

內視鏡黏膜切除術(EMR) 為早期胃腸道癌症和癌前病變的切除提供了一種微創但高效的替代傳統手術的方法，顯著改善了患者的預後和治療選擇。與創傷較大的治療方法手術相比，EMR 可使患者更快康復，術後疼痛更輕，且併發症風險更低。該技術的另一個主要優勢在於能夠維持胃腸道的完整性，使患者無需進行廣泛的切除或重組手術即可維持正常的消化功能。這對於治療巴瑞特氏食道症和早期大腸直腸癌等疾病尤其重要，因為這些疾病的治療目標是在切除異常組織的同時，最大限度地減少對患者生活品質的影響。此外，EMR 也為因年齡、合併症或病變位置等原因不適合手術的患者提供了新的治療選擇。內視鏡黏膜切除術（EMR）是一種微創手術，可在門診進行，因此能夠減輕醫療資源的負擔，並為更多患者提供可行的治療選擇。 EMR 對早期癌症的有效治療也有助於改善患者的長期預後。由於早期療育對於預防癌症進展和提高存活率至關重要，EMR 正在改變胃腸道癌症和癌前病變的治療方式，成為一種兼顧療效、患者舒適度和安全性的治療選擇。

哪些趨勢正在推動內視鏡黏膜切除術（EMR）技術市場的成長？

推動內視鏡黏膜切除術(EMR) 技術市場成長的關鍵趨勢包括：對早期癌症檢測的日益重視、內視鏡技術的進步以及對微創手術需求的不斷成長。人們越來越意識到早期檢測在成功治療胃腸道癌症的重要性，這促使大腸鏡檢查和上消化道內視鏡檢查等篩檢項目廣泛應用。隨著越來越多的病變和早期癌症被發現，對有效、微創治療方法（例如 EMR）的需求也在不斷成長。內視鏡技術的進步，例如影像技術的改進、精密儀器的開發以及混合技術的出現，也擴大了 EMR 的應用範圍，使其適用於更廣泛的患者群體和病變類型。患者和醫療服務提供者都希望獲得恢復時間更短、併發症更少、整體成本更低的治療方法方法，這推動了微創手術的普及，也是市場成長的關鍵因素。此外，與內視鏡黏膜下剝離術 (ESD) 和消融療法等新興療法的融合，也進一步拓展了 EMR 的應用範圍和市場吸引力。胃腸道疾病的日益普遍以及人口老化（老年人更容易患上這些疾病）進一步推動了市場成長。這些趨勢支持了EMR技術在現代胃腸腫瘤學中日益重要的作用，EMR技術仍然是有效治療早期癌症和癌前病變的重要且微創的選擇。

部分：

依手術技術（提起和切除、囊狀切除）、適應症（食道癌、十二指腸癌、胃癌、結腸癌）和最終用途（醫院、門診手術中心、其他最終用途）分類

受訪公司範例

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech（Nanjing）Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Global Industry Analysts 並沒有依賴通用的 LLM 或查詢產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對不同地區市場的影響。全球產業分析師預測，企業的競爭地位將根據其總部所在地、製造地以及進出口狀況（成品和OEM產品）而有所變化。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP11787

Global Endoscopic Mucosal Resection Technology Market to Reach US$5.7 Billion by 2030

The global market for Endoscopic Mucosal Resection Technology estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Lift-and-Cut Technique, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Suck-and-Cut Technique segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 7.1% CAGR

The Endoscopic Mucosal Resection Technology market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$877.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Endoscopic Mucosal Resection Technology Market - Key Trends and Drivers Summarized

How Is Endoscopic Mucosal Resection Technology Revolutionizing Gastrointestinal Cancer Treatment?

Endoscopic Mucosal Resection (EMR) technology is revolutionizing gastrointestinal cancer treatment by offering a minimally invasive, highly effective option for removing precancerous lesions and early-stage cancers from the digestive tract. EMR is particularly valuable in treating conditions such as esophageal, gastric, and colorectal cancers, where early detection and removal of abnormal tissues can prevent the progression to more advanced disease stages. This technique involves the use of an endoscope-a flexible tube equipped with a camera and instruments-to resect the mucosal layer of the gastrointestinal tract, removing the abnormal tissue without the need for traditional surgery. EMR not only reduces the risks and recovery times associated with open surgery but also preserves the integrity of the gastrointestinal tract, maintaining normal function and quality of life for patients. As awareness and screening for gastrointestinal cancers increase, EMR is becoming a preferred treatment option, transforming the landscape of cancer care by enabling early, less invasive interventions that can significantly improve patient outcomes.

What Innovations Are Enhancing the Functionality of Endoscopic Mucosal Resection Technology?

Innovations in Endoscopic Mucosal Resection (EMR) technology are enhancing its functionality through advancements in imaging, resection techniques, and adjunctive therapies. One of the most significant developments is the integration of high-definition imaging and advanced endoscopic technologies, such as narrow-band imaging (NBI) and chromoendoscopy, which allow for more precise identification and delineation of abnormal tissues. These imaging techniques enable gastroenterologists to detect even subtle lesions that might otherwise be missed, increasing the effectiveness and safety of the resection. Another key innovation is the development of hybrid EMR techniques that combine traditional resection with additional methods, such as submucosal injection or the use of specialized resection devices, to achieve more complete and controlled removal of larger or more complex lesions. This approach minimizes the risk of incomplete resection and recurrence, enhancing the long-term success of the procedure. Additionally, the combination of EMR with adjunctive therapies, such as radiofrequency ablation (RFA) or cryotherapy, is expanding its applicability to a broader range of lesions and improving outcomes for patients with more challenging cases. These innovations are making EMR more effective, safer, and accessible, solidifying its role as a critical tool in the early treatment of gastrointestinal cancers.

How Does Endoscopic Mucosal Resection Impact Patient Outcomes and Treatment Options?

Endoscopic Mucosal Resection (EMR) has a profound impact on patient outcomes and treatment options by providing a less invasive, yet highly effective alternative to traditional surgery for the removal of early-stage cancers and precancerous lesions in the gastrointestinal tract. For patients, EMR offers the potential for a quicker recovery, less postoperative pain, and a lower risk of complications compared to more invasive surgical procedures. The preservation of the gastrointestinal tract’s integrity is another significant benefit, as it allows patients to maintain normal digestive functions without the need for extensive resection or reconstruction. This is particularly important in the treatment of conditions like Barrett’s esophagus or early-stage colorectal cancer, where the goal is to remove the abnormal tissue while minimizing the impact on the patient’s quality of life. Additionally, EMR expands treatment options for patients who may not be suitable candidates for surgery due to age, comorbidities, or the location of the lesion. By offering a minimally invasive option that can be performed on an outpatient basis, EMR reduces the burden on healthcare resources and provides a viable alternative for a broader range of patients. The ability to effectively treat early-stage cancers with EMR also contributes to better long-term outcomes, as early intervention is key to preventing the progression of cancer and improving survival rates. By providing a treatment option that balances effectiveness with patient comfort and safety, EMR is transforming the management of gastrointestinal cancers and precancerous conditions.

What Trends Are Driving Growth in the Endoscopic Mucosal Resection Technology Market?

Several trends are driving growth in the Endoscopic Mucosal Resection (EMR) technology market, including the increasing emphasis on early cancer detection, advancements in endoscopic technology, and the rising demand for minimally invasive procedures. The growing awareness of the importance of early detection in the successful treatment of gastrointestinal cancers is leading to more widespread use of screening programs such as colonoscopy and upper endoscopy. As more lesions and early-stage cancers are identified, the demand for effective, minimally invasive treatment options like EMR is increasing. Advancements in endoscopic technology, including improvements in imaging, precision instrumentation, and hybrid techniques, are also expanding the capabilities of EMR, making it suitable for a wider range of patients and lesions. The shift towards minimally invasive procedures is another significant driver, as both patients and healthcare providers seek treatments that offer reduced recovery times, fewer complications, and lower overall costs. Additionally, the integration of EMR with other emerging therapies, such as endoscopic submucosal dissection (ESD) and ablative techniques, is broadening its application and appeal. The increasing prevalence of gastrointestinal conditions, coupled with an aging population that is more susceptible to these diseases, is further fueling market growth. These trends underscore the expanding role of EMR technology in modern gastrointestinal oncology, as it continues to provide a critical, less invasive option for the effective treatment of early-stage cancers and precancerous conditions.

SCOPE OF STUDY:

The report analyzes the Endoscopic Mucosal Resection Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Lift-and-Cut Technique, Suck-and-Cut Technique); Indication (Esophageal Cancer, Duodenal Cancer, Stomach Cancer, Colon Cancer); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Ambu, Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, LLC
  • Henke-Sass, Wolf GmbH
  • Micro-Tech (Nanjing) Co., Ltd
  • Olympus Corporation
  • SCHOLLY FIBEROPTIC GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Endoscopic Mucosal Resection Technology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Gastrointestinal Diseases Fueling Adoption of EMR Technology
    • Rising Demand for Minimally Invasive Surgeries in Gastroenterology
    • Integration of Digital Imaging and AI to Assist in Precise Lesion Targeting
    • Patient Preference for Procedures with Faster Recovery Times Driving EMR Utilization
    • Global Expansion of Healthcare Infrastructure Supporting Advanced Endoscopic Methods
    • Economic Analysis of Cost-Effectiveness and Benefits of EMR Over Traditional Surgeries
    • Advancements in Sedation and Pain Management for Endoscopic Procedures
    • Research Initiatives to Improve Polyp Detection and Removal Techniques
    • Future Trends in Robotic Assistance for Endoscopic Procedures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Endoscopic Mucosal Resection Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lift-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lift-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Suck-and-Cut Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Suck-and-Cut Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Stomach Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Stomach Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Duodenal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Duodenal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Endoscopic Mucosal Resection Technology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Endoscopic Mucosal Resection Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endoscopic Mucosal Resection Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by Technology - Lift-and-Cut Technique and Suck-and-Cut Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Technology - Percentage Breakdown of Value Sales for Lift-and-Cut Technique and Suck-and-Cut Technique for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by Indication - Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by Indication - Percentage Breakdown of Value Sales for Esophageal Cancer, Duodenal Cancer, Stomach Cancer and Colon Cancer for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Endoscopic Mucosal Resection Technology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Endoscopic Mucosal Resection Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION